Experimental drug doubles one-year survival in pancreatic cancer ...Middle East

Live Science - News
 Experimental drug doubles one-year survival in pancreatic cancer
A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those with advanced pancreatic cancer in a trial.

Hence then, the article about experimental drug doubles one year survival in pancreatic cancer was published today ( ) and is available on Live Science ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Experimental drug doubles one-year survival in pancreatic cancer )

Apple Storegoogle play

Last updated :

Also on site :